SMSonali V. Mohan

Sonali V. Mohan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sonali V. Mohan has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Proteogenomics analysis to identify potential sources of neoantigens and development of a pipeline for selection and prioritization of cancer neoantigens

    by Sonali Mohan

    The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.

  • Open Access

    PRELIMINARY STUDIES OF BACKGROUND REJECTION CAPABILITIES FOR THE SOUTHERN WIDE−FIELD GAMMA−RAY OBSERVATORY

    by Sonali Mohan

    The Southern Wide-field Gamma-ray Observatory (SWGO), is a next-generationgamma-ray observatory to be constructed in the Southern Hemisphere that will com-plement current and future instruments by providing a wide-field coverage of a largeportion of the southern sky and a better sensitivity to the 100 GeVs to few PeVsphoton band to understand extreme astrophysical phenomena throughout the uni-verse. Air shower events initiated by gamma rays will be recorded by the detectorand reconstructed to extract shower properties. The challenge for air-shower arraysin the observation of gamma-ray sources is the large background of hadronic cos-mic rays. Thus, the identification and separation of this background is critical. Inthis report, I present a performance study of gamma-hadron separation parametersfor the SWGO observatory using simulation data a study with a specific parametersthat measures the smoothness of the footprint in the detector array was conductedand results achieved with a SWGO reference configuration were compared to resultsconfirmed with the High-Altitude Water Cherenkov(HAWC) Observatory.

  • Open Access

    Temporal Quantitative Proteomics Reveals Proteomic and Phosphoproteomic Alterations Associated with Adaptive Response to Hypoxia in Melanoma Cells

    by Keshava K. Datta, Parthiban Periasamy, Sonali V. Mohan, Rebekah Ziegman, Harsha Gowda

    Hypoxia is a common feature in various solid tumours, including melanoma. Cancer cells in hypoxic environments are resistant to both chemotherapy and radiation. Hypoxia is also associated with immune suppression. Identification of proteins and pathways that regulate cancer cell survival in hypoxic environments can reveal potential vulnerabilities that can be exploited to improve the efficacy of anticancer therapies. We carried out temporal proteomic and phosphoproteomic profiling in melanoma cell lines to identify hypoxia-induced protein expression and phosphorylation changes. By employing a TMT-based quantitative proteomics strategy, we report the identification and quantitation of >7000 proteins and >10,000 phosphosites in melanoma cell lines grown in hypoxia. Proteomics data show metabolic reprogramming as one of the prominent adaptive responses in hypoxia. We identify several novel hypoxia-mediated phosphorylation changes that have not been reported before. They reveal kinase signalling pathways that are potentially involved in modulating cellular response to hypoxia. In addition to known protein expression changes, we identify several novel proteomic alterations associated with adaptive response to hypoxia. We show that cancer cells require the ubiquitin–proteasome system to survive in both normoxia and hypoxia. Inhibition of proteasome activity affects cell survival and may provide a novel therapeutic avenue to target cancer cells in hypoxia. Our study can serve as a valuable resource to pursue novel candidates to target hypoxia in cancers and improve the efficacy of anticancer therapies.


  • Open Access

    Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines

    by Sonali V. Mohan, Keshava K. Datta, Rebekah Ziegman, Corey Smith, Harsha Gowda


  • Signaling alterations in oral keratinocytes in response to shisha and crude tobacco extract

    by Niraj Babu, Shankargouda Patil, Sonali V. Mohan, Tejaswini Subbannayya, Jayshree Advani, Keshava K. Datta, Pavithra Rajagopalan, Firdous Ahmad Bhat, David Sidransky, Harsha Gowda, et al.

    Background Tobacco consumption in smoking and non‐smoking forms have been consequential in the rise of oral cancer cases. Among different forms, epidemiological studies from Middle Eastern countries and rural parts of northern India have reported increasing association of oral cancer with waterpipe (hookah) smoking. However, molecular mechanisms and role played by waterpipe smoking in the onset of oral carcinogenesis remains unexplored. Methods In this study, immortalized normal human oral keratinocytes were chronically treated with extracts of two varieties of waterpipe tobacco – crude tobacco and processed shisha. Phenotypic changes and molecular aberrations were examined using cell culture‐based assays and mass spectrometry‐based quantitative proteomic analysis, respectively. Bioinformatics analysis was utilized to analyze proteomics data and identify dysregulated pathways. Results Our data indicates that chronic treatment with waterpipe tobacco extracts increased proliferation, invasion, migration, and significant dysregulation of protein expression in oral keratinocytes. Altered expression of proteins involved in interferon signaling pathway were observed with both varieties of tobacco. Overexpression of cholesterol metabolism and vesicle‐mediated transport proteins were identified exclusively in cells treated with crude tobacco extract. Bioinformatics analyses revealed different oncogenic response in oral cells based on the type of waterpipe tobacco used. Conclusions This study may serve as a useful resource in understanding the early onset of oral cancer attributed to waterpipe smoking.


  • Open Access

    Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer

    by Niraj Babu, Sneha M. Pinto, Manjusha Biswas, Tejaswini Subbannayya, Manoj Rajappa, Sonali V. Mohan, Jayshree Advani, Pavithra Rajagopalan, Gajanan Sathe, Nazia Syed, et al.

    Background Phosphorylation is an important regulatory mechanism of protein activity in cells. Studies in various cancers have reported perturbations in kinases resulting in aberrant phosphorylation of oncoproteins and tumor suppressor proteins. Methods In this study, we carried out quantitative phosphoproteomic analysis of gastric cancer tissues and corresponding xenograft samples. Using these data, we employed bioinformatics analysis to identify aberrant signaling pathways. We further performed molecular inhibition and silencing of the upstream regulatory kinase in gastric cancer cell lines and validated its effect on cellular phenotype. Through an ex vivo technology utilizing patient tumor and blood sample, we sought to understand the therapeutic potential of the kinase by recreating the tumor microenvironment. Results Using mass spectrometry-based high-throughput analysis, we identified 1,344 phosphosites and 848 phosphoproteins, including differential phosphorylation of 177 proteins (fold change cut-off ≥ 1.5). Our data showed that a subset of differentially phosphorylated proteins belonged to splicing machinery. Pathway analysis highlighted Cdc2-like kinase (CLK1) as upstream kinase. Inhibition of CLK1 using TG003 and CLK1 siRNA resulted in a decreased cell viability, proliferation, invasion and migration as well as modulation in the phosphorylation of SRSF2. Ex vivo experiments which utilizes patient’s own tumor and blood to recreate the tumor microenvironment validated the use of CLK1 as a potential target for gastric cancer treatment. Conclusions Our data indicates that CLK1 plays a crucial role in the regulation of splicing process in gastric cancer and that CLK1 can act as a novel therapeutic target in gastric cancer.


  • Targeted Proteomics as a Tool for Quantifying Urine-Based Biomarkers

    by Sonali V. Mohan, D. S. Nayakanti, Gajanan Sathe, Irene A. George, Harsha Gowda, Prashant Kumar

    Mass spectrometry based proteomics approaches are routinely used to discover candidate biomarkers. These studies often use small number of samples to discover candidate proteins that are later validated on a large cohort of samples. Targeted proteomics has emerged as a powerful method for quantification of multiple proteins in complex biological matrix. Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) are two main methods of choice for quantifying and validating proteins across hundreds to thousands of samples. Over the years, many software tools have become available that enable the users to carry out the analysis. In this chapter, we describe selection of proteotypic peptides, sample preparation, generating a response curve, data acquisition and analysis of PRM data using Skyline software for targeted proteomics to quantify candidate markers in urine.


  • Chronic shisha exposure alters phosphoproteome of oral keratinocytes

    by Shankargouda Patil, Pavithra Rajagopalan, Krishna Patel, Tejaswini Subbannayya, Niraj Babu, Sonali V. Mohan, Jayshree Advani, Gajanan Sathe, Shilpa Bhandi, Hitendra S. Solanki, et al.

    Shisha smoking has been epidemiologically linked to oral cancer. However, few studies have investigated the pathobiology of shisha-induced cellular transformation. We studied the effects of chronic shisha exposure (8 months) in an in vitro model using immortalized, non-neoplastic oral keratinocytes (OKF6/TERT1). Quantitative proteomic and phosphoproteomic analyses were performed on OKF6/TERT1 cells treated with shisha extract for a period of 8 months. Pathway analysis was carried out to identify significantly enriched biological processes in shisha-treated cells. Chronic shisha exposure resulted in increased cell scattering phenomenon in OKF6/TERT1 cells. Data analysis revealed differential phosphorylation of 164 peptides (fold change ≥1.5, p ≤ 0.0.5) corresponding to 136 proteins. Proteins associated with mTORC1 and EIF4F complexes involved in initiating protein translation were seen to be enriched upon shisha treatment. Network analysis also highlighted downregulation of proteins involved in Type I interferon signaling in shisha-treated cells. Quantitative phosphoproteomic approach elucidated global perturbations to the molecular milieu of oral keratinocytes upon shisha exposure. Further studies are needed to validate putative targets in oral cancer patients with shisha smoking history.


  • Secretome analysis of oral keratinocytes chronically exposed to shisha

    by Shankargouda Patil, Niraj Babu, Tejaswini Subbannayya, Sonali V. Mohan, Gajanan Sathe, Hitendra S. Solanki, Pavithra Rajagopalan, Krishna Patel, Jayshree Advani, Shilpa Bhandi, et al.

    BACKGROUND: Shisha smoking has been associated with multiple diseases including oral cancer. However, a mechanistic study to investigate alteration of secreted proteins in oral cells due to shisha smoking is lacking. OBJECTIVES: Elucidation of differ


  • Proteomic Changes in Oral Keratinocytes Chronically Exposed to Shisha (Water Pipe)

    by Shankargouda Patil, Tejaswini Subbannayya, Sonali V. Mohan, Niraj Babu, Jayshree Advani, Gajanan Sathe, Pavithra Rajagopalan, Krishna Patel, Shilpa Bhandi, Hitendra Solanki, et al.

    Shisha (water pipe) smoking is falsely believed to be a hazard-free habit and has become a major public health concern. Studies have reported shisha smoking to be associated with oral lesions, as well as carcinomas of the lung, esophagus, bladder, and pancreas. A deeper understanding of the underlying molecular mechanisms would contribute to identification of biomarkers for targeted public health screening, therapeutic innovation, and better prognosis of associated diseases. In this study, we have established an in vitro chronic cellular model of shisha-exposed oral keratinocytes to study the effect of shisha on oral cells. Normal nontransformed, immortalized oral keratinocytes were chronically exposed to shisha extract for 8 months. This resulted in significant increase in cellular proliferation and cell invasion in shisha-exposed cells compared to the parental cells. Quantitative proteomic analysis of OKF6/TERT1-Parental and OKF6/TERT1-Shisha cells resulted in the identification of 5515 proteins. Forty-three differentially expressed proteins were found to be common across all conditions. Bioinformatic analysis of the dysregulated proteins identified in the proteomic study revealed dysregulation of interferon pathway, upregulation of proteins involved in cell growth, and downregulation of immune processes. The present findings reveal that chronic exposure of normal oral keratinocytes to shisha leads to cellular transformation and dysregulation of immune response. To the best of our knowledge, this is the first report that has developed a model of oral keratinocytes chronically exposed to shisha and identified proteomic alterations associated with shisha exposure. However, further research is required to evaluate the health burden of shisha smoking.